Nursing care
Macular Degeneration nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 6 min read · Updated September 2026
Short answer
Macular degeneration destroys central vision while peripheral vision stays intact — the reverse of glaucoma, which takes peripheral vision first. Patients lose the ability to read, recognise faces and drive, but can still navigate a room. Nursing priority is safety assessment, low-vision aid referral, and distinguishing dry from wet forms, since wet AMD needs urgent ophthalmology review.
Recognising it at the bedside
A patient with macular degeneration reports blurred or missing vision in the centre of what they're looking at, not at the edges. Ask them to look at your face: they may see your ears and hairline but not your nose or mouth. Straight lines appear wavy or bent, a distortion called metamorphopsia, which is the single most useful bedside clue you have.
Reading, recognising faces, judging colour and threading a needle become difficult early, while walking around furniture or noticing someone approach from the side stays intact. That split matters clinically. A patient who bumps into a bedside table but can still make out your face across the room does not have macular degeneration; a patient who navigates the room fine but cannot read the meal menu probably does.
Ask specifically about a family history and smoking, the two strongest modifiable and non-modifiable risk factors. Age itself is the dominant driver, hence the name age-related macular degeneration, and prevalence rises sharply past 65.
Why the classic presentation misleads
The exam pairs macular degeneration with glaucoma precisely because they invert each other. Glaucoma destroys peripheral vision first and leaves central acuity for reading until late in the disease; macular degeneration destroys central vision first and leaves peripheral awareness intact. If a question describes a patient who trips over objects but reads fine, that is glaucoma. If it describes a patient who reads poorly but moves around a room without incident, that is macular degeneration.
The trap is assuming vision loss is uniform. Students often default to "blurry vision" as a generic finding and miss which part of the visual field is actually affected. A patient with AMD may still score reasonably on a confrontation visual field test, because that test is weighted toward peripheral targets, while an Amsler grid, which tests the central ten degrees, will show grossly distorted or missing lines.
Wet AMD can mislead further because it progresses over days, not years, unlike the slow drift of dry AMD. A patient who reports sudden new central distortion needs urgent same-day ophthalmology referral, not a routine follow-up appointment.
Priority nursing actions
Assess with an Amsler grid at the bedside or on admission for any patient reporting central vision change. Ask them to focus on the central dot and describe whether any lines look wavy, broken or missing; document the specific quadrant, since this becomes the baseline for tracking progression or response to treatment.
Fall and injury risk assessment comes next. Central vision loss makes it hard to read medication labels, see food on a plate, or judge a step's edge when looking straight down, even though the patient can walk a corridor without bumping into walls. Orient the environment: describe meal trays by clock position, keep pathways free of clutter at floor level where peripheral vision still works, and use large-print or high-contrast labelling rather than assuming standard print is legible.
For a patient with sudden distortion or a new central scotoma, escalate for urgent ophthalmology review rather than routine referral, since wet AMD treated within days with intravitreal anti-VEGF injections preserves far more vision than the same treatment delayed by weeks.
Labs and diagnostics to expect
Optical coherence tomography, OCT, is the primary diagnostic tool. It images the retinal layers and detects fluid or blood under the macula, distinguishing dry AMD's drusen deposits from wet AMD's neovascular leakage. Fundus photography and fluorescein angiography confirm abnormal vessel growth when wet AMD is suspected.
There is no blood test that diagnoses AMD itself, so don't expect a specific lab marker. Genetic testing for complement factor H variants exists in research and some specialty settings but is not routine bedside practice.
Anti-VEGF agents given by intravitreal injection, bevacizumab, ranibizumab, aflibercept, are the mainstay treatment for wet AMD and are repeated on a monitored schedule rather than a single dose. Nursing documentation should track visual acuity and Amsler grid findings at each visit, since these are the functional markers used to judge whether the injection schedule is working.
Complications and their early signs
Progression from dry to wet AMD is the complication to watch for. Sudden new distortion, a dark or empty patch in central vision, or a rapid drop in reading ability in a patient previously stable on dry AMD warrants same-day evaluation, not a scheduled follow-up.
Depression and social withdrawal are common and under-assessed, since losing the ability to read, recognise loved ones' faces or drive independently strips away autonomy even when the patient can still walk and self-care physically. Screen for mood change at follow-up visits, not just visual acuity.
Falls remain the physical complication that lands patients in hospital, typically from missed steps or misjudged distances directly ahead rather than from bumping into objects to the side. Home safety assessment, adequate lighting and referral to low-vision rehabilitation reduce this risk more than any medication.
Teaching that changes outcomes
Teach the patient to self-monitor with an Amsler grid at home, once daily, one eye at a time, and to report new wavy lines or a new blank spot immediately rather than waiting for a scheduled appointment. This single habit catches wet AMD conversion early enough for anti-VEGF treatment to preserve central vision.
Reinforce that peripheral vision remains intact, which changes how patients adapt: they can still walk safely, but should stop relying on central vision for tasks like reading medication bottles or checking a glucose meter, and should be referred to low-vision services for magnifiers, large-print materials and audio alternatives.
Smoking cessation is the one modifiable risk factor with strong evidence for slowing progression, and it's worth naming directly rather than folding into generic lifestyle advice. AREDS2 vitamin formulations, containing lutein, zeaxanthin, vitamin C, vitamin E and zinc, are recommended for intermediate dry AMD to slow progression to advanced disease, though they do not restore vision already lost.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our med-surg practice questions are the closest set to what this page covers.
One question from the med-surg set
A client with chronic obstructive pulmonary disease has an oxygen saturation of 88% on 2 L/min via nasal cannula and is alert with no distress. What should the nurse do first?
Rationale
In COPD a saturation of 88–92% is the therapeutic target, not an emergency, and this client is alert with no distress. The first action is the independent nursing intervention that is least invasive and most likely to help: sit them up and reassess. Turning the oxygen up to 6 L/min risks blunting the hypoxic drive, and calling rapid response or drawing an ABG escalates ahead of an assessment you have not finished.
Answer: B
Common questions
Does macular degeneration cause total blindness?
No. Macular degeneration destroys central vision but peripheral vision is preserved, so patients retain the ability to navigate and detect movement even with advanced disease. Complete blindness is not the typical outcome, which is a key distinction from other causes of vision loss covered on the NCLEX.
What's the difference between dry and wet macular degeneration for nursing purposes?
Dry AMD progresses slowly over years and is managed with AREDS2 vitamins and monitoring. Wet AMD progresses over days to weeks due to abnormal blood vessel growth and fluid leakage under the retina, and requires urgent referral for intravitreal anti-VEGF injections to prevent rapid, often irreversible vision loss.
How is macular degeneration different from glaucoma on the exam?
Glaucoma takes peripheral vision first and spares central vision until late; macular degeneration takes central vision first and spares peripheral vision. A question describing tunnel vision or bumping into objects points to glaucoma; one describing trouble reading or distorted straight lines points to macular degeneration.
What should I teach a patient about self-monitoring at home?
Teach daily Amsler grid checks, one eye at a time, looking for new wavy, distorted or missing lines. Any sudden change should prompt same-day contact with ophthalmology, since early treatment of wet AMD preserves significantly more vision than delayed treatment.
Are anti-VEGF injections a cure?
No. They control fluid leakage and can stabilise or modestly improve vision in wet AMD, but they don't reverse existing central vision loss and require ongoing scheduled injections. Missing doses allows fluid to reaccumulate and vision to decline again.
More on med-surg